20 articles for thisTarget
              
              The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
3-Phenyl substituted 6,7-dimethoxyisoquinoline derivatives as FtsZ-targeting antibacterial agents.

The State University of New Jersey
 
N-Acetylhexosaminidase inhibitory properties of C-1 homologated GlcNAc- and GalNAc-thiazolines.

The State University of New Jersey
 
Identification of small molecule compounds with higher binding affinity to guanine deaminase (cypin) than guanine.

The State University of New Jersey
 
Exploring diverse reactive warheads for the design of SARS-CoV-2 main protease inhibitors.

The State University of New Jersey
 
Structural modification of C2-substituents on 1,4-bis(arylsulfonamido)benzene or naphthalene-N,N'-diacetic acid derivatives as potent inhibitors of the Keap1-Nrf2 protein-protein interaction.

The State University of New Jersey
 
Optimization of the C2 substituents on the 1,4-bis(arylsulfonamido)naphthalene-N,N'-diacetic acid scaffold for better inhibition of Keap1-Nrf2 protein-protein interaction.

The State University of New Jersey
 
Progress and Challenges in Targeting the SARS-CoV-2 Papain-like Protease.

The State University of New Jersey
 
Structure-activity relationships of 1,4-bis(arylsulfonamido)-benzene or naphthalene-N,N'-diacetic acids with varying C2-substituents as inhibitors of Keap1-Nrf2 protein-protein interaction.

The State University of New Jersey
 
Synthesis and Structural Characterization of Ricin Inhibitors Targeting Ribosome Binding Using Fragment-Based Methods and Structure-Based Design.

The State University of New Jersey
 
Optimization of 1,4-bis(arylsulfonamido)naphthalene-N,N'-diacetic acids as inhibitors of Keap1-Nrf2 protein-protein interaction to suppress neuroinflammation.

The State University of New Jersey
 
Novel Sigma 1 Receptor Antagonists as Potential Therapeutics for Pain Management.

The State University of New Jersey
 
Discovery of disubstituted xylylene derivatives as small molecule direct inhibitors of Keap1-Nrf2 protein-protein interaction.

The State University of New Jersey
 
Discovery of a small-molecule inhibitor and cellular probe of Keap1-Nrf2 protein-protein interaction.

The State University of New Jersey
 
Inhibitors of cyclin-dependent kinase 7 and uses thereof

Dana-Farber Cancer Institute
 
Oxexin 1 receptor antagonists

Nxera Pharma UK
 
NOVEL CYCLOPROPYL COMPOUNDS

Icagen
 
Substituted 1,2-oxaborolan-2-ols as PDE4 inhibitors

Pfizer
 
Dihydropyrrolopyridine inhibitors of ROR-gamma

Vitae Pharmaceuticals
 
Enzyme inhibition by hydroamination: design and mechanism of a hybrid carmaphycin-syringolin enone proteasome inhibitor.

University of California San Diego
 
Substituted imidazopyridinyl-aminopyridine compounds

Arqule